Phase I-II

Pfizer, Biogen-led blockchain project demonstrates proof-of-concept in pursuit of a better supply chain

14-Aug-2019 By Melissa Fassbender

The multi-stakeholder group is developing a blockchain-powered platform to increase transparency and collaboration in the clinical trial supply chain – and has successfully completed a proof-of-concept project, now looking to next steps.

Cryoport sees no slowdown ahead: ‘The wind continues to be at our back’

14-Aug-2019 By Melissa Fassbender

The temperature-controlled logistics company expects demand to continue, with long-term plans to build out its bioservices operations – and a ‘revolutionary’ cryogenic storage system in the works.

VitaLink acquires Comprehensive Clinical Trials

13-Aug-2019 By Melissa Fassbender

The clinical research site business, VitaLink Research, has acquired FL-based Comprehensive Clinical Trials, which conducts women’s health-focused Ph II-IV clinical trials.

Boehringer Ingelheim, MD Anderson launch virtual research and development center

13-Aug-2019 By Maggie Lynch

Boehringer Ingelheim and the University of Texas MD Anderson Cancer Center entered a multi-year partnership to conduct collaborative translational research for lung and GI cancers.

Saama acquires Comprehend, combining strengths and elevating ability to innovate

13-Aug-2019 By Melissa Fassbender

Saama Technologies today announced that it has signed a definitive agreement to acquire Comprehend Systems, creating an ‘enhanced suite of complementary capabilities’ to ‘facilitate more rapid drug development,’ says company executives.

Cancer Research UK backs Hummingbird’s cancer treatment development

13-Aug-2019 By Vassia Barba

Cancer Research UK to support the clinical development of Hummingbird’s investigative cancer treatment which has the potential to fight drug resistant tumours.

WCG acquires PharmaSeek, to offer ‘unprecedented’ site support and guidance

12-Aug-2019 By Melissa Fassbender

Through the combined offerings of WCG and PharmaSeek, the companies will be able to make a clinical trial site’s success both ‘predictable and achievable,’ says CEO.

BioIVT continues biospecimen buy up with Keystone Biologicals deal

12-Aug-2019 By Melissa Fassbender

The provider research models and services, BioIVT, has acquired Hatboro-PA-based Keystone Biologicals, which supplies disease-state plasma, sera, and controls.

CRO earnings roundup: Big pharma picking up biotech slack?

09-Aug-2019 By Melissa Fassbender

Big pharma is driving demand for CROs, backed by promising pipelines and an ‘appetite to spend,’ says analyst.

Clinerion expands its patient network with addition of Greek hospital

08-Aug-2019 By Maggie Lynch

Ever-expanding Clinerion adds another hospital to its Patient Network Explorer platform bringing clinical research to patients in Greece and expanding its client’s patient population coverage.

C-Path and NORD collaborate to establish rare disease data platform

08-Aug-2019 By Maggie Lynch

The Critical Path Institute and National Organization for Rare Disorders are developing a new data and analytics platform to inform clinical trial design and advance therapies for rare diseases.

Data standard to have ‘a systemic impact on the entire health care ecosystem’: Oracle

08-Aug-2019 By Melissa Fassbender

Last week, leaders from Amazon, Google, IBM, Microsoft, Oracle, and Salesforce reaffirmed a previously made commitment to interoperability among health information technology.

Innovation at scale: Oracle, HCL look to clear an ‘easy adoption path’ for mHealth in clinical trials

08-Aug-2019 By Melissa Fassbender

HCL Technologies and Oracle Health Sciences announce a collaboration to “bridge the gap” between the potential of mobile health and the realities of adoption, says EVP.

‘A tsunami of change coming to clinical development’: AbbVie talks digital disruption

07-Aug-2019 By Maggie Lynch

At a time when innovation is rapid, clinical development is evolving at the same pace, and new technologies are bringing disruptive opportunities to research, says AbbVie executive.

‘The future is challenging us to innovate our delivery methods’: PRA

06-Aug-2019 By Melissa Fassbender

Biopharmaceutical companies are increasingly relying on CROs in Japan, says an executive with PRA, which recently established a new subsidiary in the country.